Deutsch English Français

Contact

EP1113788

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP1113788

EP1113788 - TRANSDERMAL DEVICES COMPRISING ESSENTIAL OILS FOR AROMATHERAPY [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 04.02.2005 Database last updated on 15.07.2024
Most recent event Tooltip	04.02.2005	Application deemed to be withdrawn	published on 23.03.2005 [2005/12]
Applicant(s)	For all designated states Lavipharm Laboratories, Inc. Suite 6, 131 Ethel Road West Piscataway, NJ 08854 / US
	[2001/28]
Inventor(s)	01 / FOTINOS, Spiros 18A J. Statha GR-106 72 Athens / GR
	[2001/28]
Representative(s)	Breesé, Pierre Novagraaf Technologies 122, rue Edouard Vaillant 92593 Levallois-Perret Cedex / FR
	[N/P]
Former [2001/28]	Breese, Pierre Breese - Majerowicz - Simonnot 3, avenue de l'Opéra 75001 Paris / FR
Application number, filing date	99969330.2	17.09.1999
	[2001/28]
	WO1999US21580
Priority number, date	US19980100994P	18.09.1998 Original published format: US 100994 P
	[2001/28]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO0016752
	Date:	30.03.2000
	Language:	EN
	[2000/13]
	Type:	A2 Application without search report
	No.:	EP1113788
	Date:	11.07.2001
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 30.03.2000 takes the place of the publication of the European patent application.
	[2001/28]
Search report(s)	International search report - published on:	EP	08.06.2000
Classification	IPC:	A61K9/70, A61K9/12, A61K35/78	[2001/28]
	CPC:	A61Q13/00 (EP,US); A61K36/00 (EP); A61K8/0208 (EP); A61K8/0212 (EP); A61K8/645 (EP); A61K8/68 (EP); (+) A61K8/731 (EP); A61K8/736 (EP); A61K8/738 (EP); A61K8/8129 (EP); A61K8/922 (EP); A61K8/927 (EP); A61K8/9761 (EP,US); A61K8/9767 (EP,US); A61K8/9789 (EP,US); A61K8/9794 (EP,US); A61K9/007 (EP); A61K9/7084 (EP); A61Q19/00 (EP); A61K47/32 (EP); A61Q19/007 (EP); A61Q19/008 (EP) (-)
	C-Set:	A61K36/00, A61K2300/00 (EP)
Designated contracting states	AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2001/28]
Extension states	AL	Not yet paid
	LT	Not yet paid
	LV	Not yet paid
	MK	Not yet paid
	RO	Not yet paid
	SI	Not yet paid
Title	German:	PFLASTER MIT ÄTHERISCHEN ÖLEN ZUR AROMATHERAPIE	[2001/28]
	English:	TRANSDERMAL DEVICES COMPRISING ESSENTIAL OILS FOR AROMATHERAPY	[2001/28]
	French:	DISPOSITIFS TRANSDERMIQUES COMPRENANT DES HUILES ESSENTIELLES POUR AROMATHERAPIE	[2001/28]
Entry into regional phase	22.03.2001	National basic fee paid
	22.03.2001	Designation fee(s) paid
	22.03.2001	Examination fee paid
Examination procedure	18.04.2000	Request for preliminary examination filed International Preliminary Examining Authority: US
	22.03.2001	Examination requested [2001/28]
	29.11.2002	Despatch of a communication from the examining division (Time limit: M06)
	12.05.2003	Reply to a communication from the examining division
	29.04.2004	Despatch of a communication from the examining division (Time limit: M04)
	10.09.2004	Application deemed to be withdrawn, date of legal effect [2005/12]
	15.10.2004	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2005/12]
Fees paid	Renewal fee
	25.09.2001	Renewal fee patent year 03
	27.09.2002	Renewal fee patent year 04
	29.03.2004	Renewal fee patent year 05
	Penalty fee
	Additional fee for renewal fee
	30.09.2003	05 M06 Fee paid on 29.03.2004
	30.09.2004	06 M06 Not yet paid
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[X]US5456745 (ROREGER MICHAEL [DE], et al) [X] 1,3-9,11-17,19,28-36,38-43,45-49 * column 16 - column 17; examples 23,24 *;
		[X]US4681635 (STIEFEL WERNER K [US], et al) [X] 20-26 * example - * * claim - *;
		[X]FR2147246 (BRISTOL MYERS CO) [X] 20-27 * page 24; example 18 *;
		[X]DE2011235 (HEIMBACH R. ET AL) [X] 1,3-9,19-27 * page 2; claims 1-3 *;
		[X]EP0647913 (SYSTEMFORM GMBH [DE]) [X] 1-9,11-16,19,28-36,38-42,45-49 * page 2, line 6 - line 18 * * page 4, line 18 - line 26 * * page 4, line 54 - line 55 * * page 5 - page 8; examples 6,17,30,43 *;
		[X]WO9115117 (BASIC BIO SYSTEMS INC [US]) [X] 20 * page 8, line 13 - line 26 * * page 30, line 10 - line 25 * * page 33, line 5 - line 24 *;
		[X]WO9206701 (HUFFSTUTLER M CONRAD JR [US]) [X] 1,3,28,29,34,35,45-48 * page 4, line 16 - line 21 * * page 5, line 10 - line 35 * * page 13; examples C3,,D1 *;
		[X]US4729190 (LEE PING I [US]) [X] 28-31,34,35,38-42,45-47 * column 2, line 46 - line 50 * * column 3, line 52 - column 4, line 9 * * column 14 - column 17; examples 15,17 *;
		[X]EP0750905 (KAO CORP [JP]) [X] 1-8,11-14,19,28-35,38-40,45-49 * page 2, line 5 - line 9 * * page 2, line 46 - line 58 * * page 3, line 17 - line 36 * * page 5, line 46 - line 56 * * page 8, line 55 - line 58 * * page 9 - page 11; examples 1-10 *;
		[X]GB1122796 (GUSTAVE GIRARDIERE) [X] 1,3,4,20,28-30 * page 1, line 75 - page 2, line 32 * * page 3; examples 5-7 *;
		[PX]WO9917738 (LAVIPHARM LAB INC [US]) [PX] 1,3-43,45-49 * page 16 - page 18; example 4 * * page 20; example 9 * * page 21 - page 23; example 11 *
		[X] - SANTUS G C ET AL, "TRANSDERMAL ENHANCER PATENT LITERATURE", JOURNAL OF CONTROLLED RELEASE,NL,ELSEVIER SCIENCE PUBLISHERS B.V. AMSTERDAM, (19930527), vol. 25, no. 1 / 02, ISSN 0168-3659, pages 1 - 20, XP000361364 [X] 28-30 * page 11 * DOI: http://dx.doi.org/10.1016/0168-3659(93)90090-R
		[A] - KENJU SUGIBAYASHI ET AL, "POLYMERS FOR TRANSDERMAL DRUG DELIVERY SYSTEMS", JOURNAL OF CONTROLLED RELEASE,NL,ELSEVIER SCIENCE PUBLISHERS B.V. AMSTERDAM, (19940201), vol. 29, no. 1/02, ISSN 0168-3659, pages 177 - 185, XP000433662 [A] 1-49 * the whole document * DOI: http://dx.doi.org/10.1016/0168-3659(94)90134-1

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 35p